3

 

Issues in the Control of Genome Information: From Discussions at the Committee’s Workshop

 

39

   

 Stakeholders in the Debate over Release of Genome Data,

 

40

   

 Domestic Interest Groups and Perspectives,

 

41

   

 International Issues,

 

43

   

 Categories of Genome Data,

 

44

   

 Data from Bioterror Agents vs. Other Pathogens,

 

45

   

 Data from Naturally Occurring vs. Genetically Engineered Pathogens,

 

45

   

 Primary Genome Sequences vs. Annotations,

 

46

   

 Microarray and Other Functional Genome Data,

 

46

   

 Tools for Analyzing Genome Data,

 

47

   

 Potential Data-Control Mechanisms,

 

47

   

 Classify Some Data,

 

48

   

 Withhold Some Data from Widespread Public Release,

 

48

   

 Allow Unlimited Data Access but Require Registration,

 

49

   

 Summary of Issues Related to Restricting Access to Genome Data,

 

50

4

 

Conclusions and Recommendations

 

52

   

 Recommendation 1,

 

52

   

 Current Polices Are Effective,

 

53

   

 Effective Restriction of Genome Data Is Not Practical,

 

54

   

 Pathogen Genome Sequences Are Not Uniquely Dangerous,

 

55

   

 Recommendation 2,

 

57

   

 Recommendation 3,

 

58

   

 Recommendation 4,

 

62

   

 Recommendation 5,

 

64

 

 

References

 

65

 

 

Appendixes

 

 

A

 

Statement of Task

 

69

B

 

Agenda

 

71

C

 

Participants

 

73



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement